DSUVIA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Dsuvia, and when can generic versions of Dsuvia launch?
Dsuvia is a drug marketed by Vertical Pharms and is included in one NDA. There are twenty patents protecting this drug.
This drug has one hundred and five patent family members in twenty countries.
The generic ingredient in DSUVIA is sufentanil citrate. There are nine drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the sufentanil citrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dsuvia
A generic version of DSUVIA was approved as sufentanil citrate by HIKMA on December 15th, 1995.
Summary for DSUVIA
International Patents: | 105 |
US Patents: | 20 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 22 |
Clinical Trials: | 3 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for DSUVIA |
What excipients (inactive ingredients) are in DSUVIA? | DSUVIA excipients list |
DailyMed Link: | DSUVIA at DailyMed |
Recent Clinical Trials for DSUVIA
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Frank Guyette | Phase 3 |
United States Department of Defense | Phase 3 |
Montefiore Medical Center | Phase 4 |
Pharmacology for DSUVIA
Drug Class | Opioid Agonist |
Mechanism of Action | Full Opioid Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for DSUVIA
US Patents and Regulatory Information for DSUVIA
DSUVIA is protected by twenty US patents.
Patents protecting DSUVIA
Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF ACUTE PAIN
Small-volume oral transmucosal dosage forms
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF ACUTE PAIN
Storage and dispensing devices for administration of oral transmucosal dosage forms
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Small-volume oral transmucosal dosage forms
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF ACUTE PAIN
Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF ACUTE PAIN
Small-volume oral transmucosal dosage
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Bioadhesive drug formulations for oral transmucosal delivery
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Bioadhesive drug formulations for oral transmucosal delivery
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF ACUTE PAIN
Storage and dispensing devices for administration of oral transmucosal dosage forms
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF ACUTE PAIN
Small-volume oral transmucosal dosage forms
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF ACUTE PAIN
Bioadhesive drug formulations for oral transmucosal delivery
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF ACUTE PAIN
Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF ACUTE PAIN
Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF ACUTE PAIN
Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
International Patents for DSUVIA
See the table below for patents covering DSUVIA around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
European Patent Office | 2612645 | Dispositifs de stockage et de distribution de médicaments et systèmes comprenant ceux-ci (Drug storage and dispensing devices and systems comprising the same) | ⤷ Try a Trial |
China | 101626750 | Storage and dispensing devices for administration of oral transmucosal dosage forms | ⤷ Try a Trial |
China | 101495080 | Drug storage and dispensing devices and systems comprising the same | ⤷ Try a Trial |
Spain | 2396150 | ⤷ Try a Trial | |
Portugal | 2114383 | ⤷ Try a Trial | |
Canada | 2848274 | DISPOSITIFS DE DISTRIBUTION ET DE STOCKAGE DE MEDICAMENTS ET SYSTEMES COMPRENANT CEUX-CI (DRUG STORAGE AND DISPENSING DEVICES AND SYSTEMS COMPRISING THE SAME) | ⤷ Try a Trial |
Mexico | 2011005370 | FORMAS DE DOSIS ORALES DE SUFENTANILO QUE COMPRENDEN AGENTES BARREDORES DE OXÍGENO Y MÉTODOS DE USO DE LOS MISMOS. (SUFENTANIL SOLID DOSAGE FORMS COMPRISING OXYGEN SCAVENGERS AND METHODS OF USING THE SAME.) | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for DSUVIA
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2114383 | 16C0010 | France | ⤷ Try a Trial | PRODUCT NAME: SUFENTANIL; REGISTRATION NO/DATE: EU/1/15/1042 20150918 |
2114383 | 122016000023 | Germany | ⤷ Try a Trial | PRODUCT NAME: SUFENTANIL, WAHLWEISE IN FORM VON SUFENTANILCITRAT; REGISTRATION NO/DATE: EU/1/15/1042 20150918 |
2114383 | SPC/GB16/004 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: SUFENTANIL; REGISTERED: UK EU/1/15/1042 20150922 |
2114383 | CA 2016 00007 | Denmark | ⤷ Try a Trial | PRODUCT NAME: SUFENTANIL, HERUNDER SUFENTANIL SOM CITRAT; REG. NO/DATE: EU/1/15/1042/001-006 20150922 |
2114383 | CR 2016 00007 | Denmark | ⤷ Try a Trial | PRODUCT NAME: SUFENTANIL; REG. NO/DATE: EU/1/15/1042/001-006 20150922 |
2114383 | 300797 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: SUFENTANIL, DESGEWENST IN DE VORM VAN SUFENTANILCITRAAT; REGISTRATION NO/DATE: EU/1/15/1042 20150922 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |